Rel-(1R,3S)-3-methoxycyclopentan-1-amine

Catalog No.: 
ACDKLR906
CAS No.: 
1268522-02-6
Molecular Formula: 
C6H13NO
Molecular Weight: 
115.1
Rel-(1R,3S)-3-methoxycyclopentan-1-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$142.00In stockInquiry
100mg97%$241.00In stockInquiry
250mg97%$321.00In stockInquiry
1g97%$669.00In stockInquiry
5g97%$2810.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(1R,3S)-3-methoxycyclopentan-1-amine
IUPAC NameRel-(1R,3S)-3-methoxycyclopentan-1-amine
MDL No.MFCD31727893
Molecular FormulaC6H13NO
Molecular Weight115.1
SMILESCO[C@@H]1C[C@@H](CC1)N
InChI KeyBVILPGWUKJERFN-RITPCOANSA-N
Synonym(1R,3S)-3-Methoxycyclopentan-1-aMine;(1S,3S)-3-Methoxycyclopentan-1-aMine;Cyclopentanamine, 3-methoxy-, (1R,3S)-rel-;cis-3-Methoxycyclopentan-1-amine
CAS No.1268522-02-6

Safety Data

Pictogram
FlammableCorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H226-H302-H314
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P370+P378-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACDKLR906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKLR906 route product structure diagram
    ACDKLR9061268522-02-6In Stock
Inquiry

2. ACDKLR906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKLR906 route product structure diagram
    ACDKLR9061268522-02-6In Stock
Inquiry

3. ACDKLR906 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDKLR906 route product structure diagram
    ACDKLR9061268522-02-6In Stock
Inquiry

Comments (0)